News Conference News TCT 2016 Novel SES Fails to Match Xience EES for Chronic Total Occlusions Yael L. Maxwell November 08, 2016
News Conference News TCT 2016 RIBS VI: Absorb BVS Safe in In-Stent Restenosis but Fails to Best Xience Metallic Stent Michael O'Riordan November 08, 2016
News Opinion Editor's Corner TCT 2016 My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway Shelley Wood November 07, 2016
News Conference News TCT 2016 ILLUMENATE: Low-Dose DCB Bests Angioplasty Alone in Complex Patients With SFA/Popliteal Lesions L.A. McKeown November 07, 2016
News Industry News TCT 2016 Hybrid Sirolimus-Eluting Stents with Biodegradable Polymer Did Not Improve Angiographic Outcomes Compared to Everolimus-Eluting Stents with Durable Polymer in Treatment of Chronic Total Occlusions November 02, 2016
Presentation TCT 2016 AMULET OBSERVATIONAL STUDY: Multicenter, Prospective, Registry Results With a Left Atrial Appendage Closure Device for Stroke Prevention in Patients With Atrial Fibrillation Presenter: Martin B. Leon, Louis A. Cannon, David Hildick-Smith November 02, 2016
Presentation TCT 2016 WATCHMAN US POST-APPROVAL STUDY: Multicenter, Prospective, Registry Results With a Left Atrial Appendage Closure Device for Stroke Prevention in Patients With Atrial Fibrillation Presenter: Martin B. Leon, Louis A. Cannon, David R. Holmes Jr. November 02, 2016
News Conference News TCT 2016 Debate Over Low-Risk TAVR Hinges on Definition of Patient Population and Shared Decision-Making Yael L. Maxwell November 02, 2016
Presentation TCT 2016 ILLUMENATE U.S.: A Prospective, Randomized Trial of a Paclitaxel-Coated Balloon vs an Uncoated Balloon for Treatment of Diseased Superficial Femoral and Popliteal Arteries Presenter: Martin B. Leon, Louis A. Cannon, Sean P. Lyden November 02, 2016
News Conference News TCT 2016 Transfemoral—but Not Transthoracic—TAVR Has Early Quality-of-Life Advantage Over Surgery in Intermediate-Risk Patients Todd Neale November 02, 2016
News Conference News TCT 2016 COLOR: PCI of Lipid-Rich Plaque Not Associated With Increased Risk of Adverse Events Michael O'Riordan November 01, 2016
Presentation TCT 2016 Cerebral Embolic Protection II: The Keystone Deflector - Design Features and Updates From Deflect III and Reflect Clinical Trials Presenter: Helene Eltchaninoff, Neal S. Kleiman, Andreas Baumbach November 01, 2016
Presentation TCT 2016 What Should Be the Next Series of Clinical Trials in PFO Closure? Presenter: Eustaquio Maria Onorato, Richard Smalling, John D. Carroll November 01, 2016
Presentation TCT 2016 What Do the Randomized Clinical Trials Tell Us and How Did the FDA Respond? Presenter: John D. Carroll, Christian Spies November 01, 2016
Presentation TCT 2016 To Pretreat or Not to Pretreat? The DUBIUS Trial Presenter: Roxana Mehran, Ferdinando Varbella, Giuseppe Tarantini November 01, 2016
Presentation TCT 2016 Accurate: Design Features, Special Attributes, and Clinical Trial Program Presenter: Eberhard Grube, James B. Hermiller Jr., Helge Möllmann November 01, 2016
News Conference News TCT 2016 Midterm Durability of TAVR Valves: PARTNER, Other Studies Boost Confidence Todd Neale November 01, 2016
Presentation TCT 2016 Direct Flow: Design Features, Special Attributes, and Clinical Trial Program Presenter: Eberhard Grube, James B. Hermiller Jr., Azeem Latib November 01, 2016
News Industry News TCT 2016 Study Finds No Long-Term Clinical Benefit to Routine Follow-Up Coronary Angiography After PCI November 01, 2016
Presentation TCT 2016 Lotus and EDGE: Design Features, Special Attributes, and Clinical Trial Program Presenter: Eberhard Grube, James B. Hermiller Jr., Ted Feldman November 01, 2016